tert-butylbicyclo-2-benzoate has been researched along with felbamate in 1 studies
Studies (tert-butylbicyclo-2-benzoate) | Trials (tert-butylbicyclo-2-benzoate) | Recent Studies (post-2010) (tert-butylbicyclo-2-benzoate) | Studies (felbamate) | Trials (felbamate) | Recent Studies (post-2010) (felbamate) |
---|---|---|---|---|---|
52 | 0 | 2 | 457 | 41 | 49 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albin, RL; Greenfield, LJ; Kume, A; Macdonald, RL | 1 |
1 other study(ies) available for tert-butylbicyclo-2-benzoate and felbamate
Article | Year |
---|---|
Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor.
Topics: Animals; Anticonvulsants; Autoradiography; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Chloride Channels; Dose-Response Relationship, Drug; Felbamate; Male; Mice; Phenylcarbamates; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 1996 |